134 related articles for article (PubMed ID: 7796584)
1. A computer program linking physiologically based pharmacokinetic model with cancer risk assessment for breast-fed infants.
Byczkowski JZ; Fisher JW
Comput Methods Programs Biomed; 1995 Feb; 46(2):155-63. PubMed ID: 7796584
[TBL] [Abstract][Full Text] [Related]
2. Lactational transfer of tetrachloroethylene in rats.
Byczkowski JZ; Fisher JW
Risk Anal; 1994 Jun; 14(3):339-49. PubMed ID: 8029506
[TBL] [Abstract][Full Text] [Related]
3. Computer simulation of the lactational transfer of tetrachloroethylene in rats using a physiologically based model.
Byczkowski JZ; Kinkead ER; Leahy HF; Randall GM; Fisher JW
Toxicol Appl Pharmacol; 1994 Apr; 125(2):228-36. PubMed ID: 8171430
[TBL] [Abstract][Full Text] [Related]
4. Variability of physiologically based pharmacokinetic (PBPK) model parameters and their effects on PBPK model predictions in a risk assessment for perchloroethylene (PCE).
Gearhart JM; Mahle DA; Greene RJ; Seckel CS; Flemming CD; Fisher JW; Clewell HJ
Toxicol Lett; 1993 May; 68(1-2):131-44. PubMed ID: 8516760
[TBL] [Abstract][Full Text] [Related]
5. Linking indoor air and pharmacokinetic models to assess tetrachloroethylene risk.
Bogen KT; McKone TE
Risk Anal; 1988 Dec; 8(4):509-20. PubMed ID: 3244858
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of physiologically based pharmacokinetic models in risk assessment: an example with perchloroethylene.
Clewell HJ; Gentry PR; Kester JE; Andersen ME
Crit Rev Toxicol; 2005 Jun; 35(5):413-33. PubMed ID: 16097137
[TBL] [Abstract][Full Text] [Related]
7. Use of a physiologically based model to predict systemic uptake and respiratory elimination of perchloroethylene.
Dallas CE; Muralidhara S; Chen XM; Ramanathan R; Varkonyi P; Gallo JM; Bruckner JV
Toxicol Appl Pharmacol; 1994 Sep; 128(1):60-8. PubMed ID: 8079355
[TBL] [Abstract][Full Text] [Related]
8. Development of a physiologically based pharmacokinetic model for perchloroethylene using tissue concentration-time data.
Dallas CE; Chen XM; O'Barr K; Muralidhara S; Varkonyi P; Bruckner JV
Toxicol Appl Pharmacol; 1994 Sep; 128(1):50-9. PubMed ID: 8079354
[TBL] [Abstract][Full Text] [Related]
9. Lactational transfer of volatile chemicals in breast milk.
Fisher J; Mahle D; Bankston L; Greene R; Gearhart J
Am Ind Hyg Assoc J; 1997 Jun; 58(6):425-31. PubMed ID: 9183837
[TBL] [Abstract][Full Text] [Related]
10. Physiologically based pharmacokinetic model useful in prediction of the influence of species, dose, and exposure route on perchloroethylene pharmacokinetics.
Dallas CE; Chen XM; Muralidhara S; Varkonyi P; Tackett RL; Bruckner JV
J Toxicol Environ Health; 1995 Mar; 44(3):301-17. PubMed ID: 7897693
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of toxic chemicals in breast milk: use of PBPK models to predict infant exposure.
Clewell RA; Gearhart JM
Environ Health Perspect; 2002 Jun; 110(6):A333-7. PubMed ID: 12055064
[TBL] [Abstract][Full Text] [Related]
12. Acute perchloroethylene exposure alters rat visual-evoked potentials in relation to brain concentrations.
Boyes WK; Bercegeay M; Oshiro WM; Krantz QT; Kenyon EM; Bushnell PJ; Benignus VA
Toxicol Sci; 2009 Mar; 108(1):159-72. PubMed ID: 19098276
[TBL] [Abstract][Full Text] [Related]
13. Physiologically based pharmacokinetic modeling of the lactational transfer of methylmercury.
Byczkowski JZ; Lipscomb JC
Risk Anal; 2001 Oct; 21(5):869-82. PubMed ID: 11798123
[TBL] [Abstract][Full Text] [Related]
14. Predicted infant exposure to tetrachloroethene in human breastmilk.
Schreiber JS
Risk Anal; 1993 Oct; 13(5):515-24. PubMed ID: 8259441
[TBL] [Abstract][Full Text] [Related]
15. Dietary Iodine Sufficiency and Moderate Insufficiency in the Lactating Mother and Nursing Infant: A Computational Perspective.
Fisher W; Wang J; George NI; Gearhart JM; McLanahan ED
PLoS One; 2016; 11(3):e0149300. PubMed ID: 26930410
[TBL] [Abstract][Full Text] [Related]
16. The use of Markov chain Monte Carlo uncertainty analysis to support a Public Health Goal for perchloroethylene.
Covington TR; Robinan Gentry P; Van Landingham CB; Andersen ME; Kester JE; Clewell HJ
Regul Toxicol Pharmacol; 2007 Feb; 47(1):1-18. PubMed ID: 16901594
[TBL] [Abstract][Full Text] [Related]
17. Application of in vitro biotransformation data and pharmacokinetic modeling to risk assessment.
Kedderis GL; Lipscomb JC
Toxicol Ind Health; 2001 Jun; 17(5-10):315-21. PubMed ID: 12539878
[TBL] [Abstract][Full Text] [Related]
18. Improving cancer dose-response characterization by using physiologically based pharmacokinetic modeling: an analysis of pooled data for acrylonitrile-induced brain tumors to assess cancer potency in the rat.
Kirman CR; Hays SM; Kedderis GL; Gargas ML; Strother DE
Risk Anal; 2000 Feb; 20(1):135-51. PubMed ID: 10795346
[TBL] [Abstract][Full Text] [Related]
19. Incorporation of
Clewell HJ; Campbell JL; Van Landingham C; Franzen A; Yoon M; Dodd DE; Andersen ME; Gentry PR
Inhal Toxicol; 2019; 31(13-14):468-483. PubMed ID: 31992090
[No Abstract] [Full Text] [Related]
20. PBPK modeling of the percutaneous absorption of perchloroethylene from a soil matrix in rats and humans.
Poet TS; Weitz KK; Gies RA; Edwards JA; Thrall KD; Corley RA; Tanojo H; Hui X; Maibach HI; Wester RC
Toxicol Sci; 2002 May; 67(1):17-31. PubMed ID: 11961212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
